Bon Adamson is a writer with a passion for technology and help desk experience, with a particular interest in Apple's product ecosystem. Bon has been writing for the majority of his life. He is ...
Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...
Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond ...
Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced the launch of its new adeno-associated virus (AAV) transduction application for the Liver ...
A Boston startup known for its plastic chips that simulate human organs announced the appointment of a new CEO on Thursday as it ramps up its commercial portfolio with new funding. Jim Corbett will ...
Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) ...
This article was first published in the May 2016 issue of WIRED magazine. Be the first to read WIRED's articles in print before they're posted online, and get your hands on loads of additional content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback